{"id":{"repo_id":"usfca","oai_identifier":"oai:repository.usfca.edu:capstone-3022"},"canonical_url":"https://search.ndltd.org/etd/usfca/oai:repository.usfca.edu:capstone-3022","repository":{"repo_id":"usfca","name":"University of San Francisco","base_url":"https://repository.usfca.edu/do/oai/"},"display":{"title":"Improving Minors' Access to Treatment for Opioid Use Disorder: A Policy Analysis","abstract":"As the opioid epidemic continues to have devastating effects on our communities, medications to treat opioid use disorder (MOUDs) are severely underutilized especially for adolescents. Unlike adults, minors need parental approval before obtaining MOUDs presenting a key barrier to timely treatment. Being able to treat adolescents as soon as they are ready is critically important for people with OUD, and while cost and other barriers have been addressed in the literature, there is a paucity on how parental consent affects the accessibility of treatment. This paper aims to explore a potential policy in California that addresses the lack of access for adolescents. A health policy analysis format was used to compare and assess each policy option through a criteria of feasibility, effectiveness, relevance, and impact. Peer-reviewed articles and public health data was utilized for this analysis. After a comparison of two policy options, the more favorable option was a revision to California’s minor consent laws to allow providers to confidentially treat addicted youth, 16 and older, with buprenorphine. This analysis showed how this policy will likely be more effective in narrowing the treatment gap among older adolescents. Recommendations, implications and potential limitations were also discussed.","abstract_html":"As the opioid epidemic continues to have devastating effects on our communities, medications to treat opioid use disorder (MOUDs) are severely underutilized especially for adolescents. Unlike adults, minors need parental approval before obtaining MOUDs presenting a key barrier to timely treatment. Being able to treat adolescents as soon as they are ready is critically important for people with OUD, and while cost and other barriers have been addressed in the literature, there is a paucity on how parental consent affects the accessibility of treatment. This paper aims to explore a potential policy in California that addresses the lack of access for adolescents. A health policy analysis format was used to compare and assess each policy option through a criteria of feasibility, effectiveness, relevance, and impact. Peer-reviewed articles and public health data was utilized for this analysis. After a comparison of two policy options, the more favorable option was a revision to California’s minor consent laws to allow providers to confidentially treat addicted youth, 16 and older, with buprenorphine. This analysis showed how this policy will likely be more effective in narrowing the treatment gap among older adolescents. Recommendations, implications and potential limitations were also discussed.","abstract_has_math":false,"creators":["Hamilton, Sara Jane"],"institution":null,"degree_name":"Master of Public Health (MPH)","degree_level":"Project/Capstone - Global access","degree_discipline":"Public Health","degree_department":null,"school":null,"contributors":["Alexa Curtis"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:38:22Z","subjects":["Opioid use disorder","Minor consent","parental consent","policy analysis","California","Epidemiology","Health Services Administration","Other Mental and Social Health","Psychiatric and Mental Health","Substance Abuse and Addiction"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://repository.usfca.edu/capstone/1665","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://repository.usfca.edu/capstone/1665","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://repository.usfca.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Arepository.usfca.edu%3Acapstone-3022","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Alexa Curtis"]},{"key":"dc:creator","label":"Author","values":["Hamilton, Sara Jane"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-01-29T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2023-08-11T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Public Health"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Project/Capstone - Global access"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Public Health (MPH)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Opioid use disorder","Minor consent","parental consent","policy analysis","California","Epidemiology","Health Services Administration","Other Mental and Social Health","Psychiatric and Mental Health","Substance Abuse and Addiction"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://repository.usfca.edu/capstone/1665"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["As the opioid epidemic continues to have devastating effects on our communities, medications to treat opioid use disorder (MOUDs) are severely underutilized especially for adolescents. Unlike adults, minors need parental approval before obtaining MOUDs presenting a key barrier to timely treatment. Being able to treat adolescents as soon as they are ready is critically important for people with OUD, and while cost and other barriers have been addressed in the literature, there is a paucity on how parental consent affects the accessibility of treatment. This paper aims to explore a potential policy in California that addresses the lack of access for adolescents. A health policy analysis format was used to compare and assess each policy option through a criteria of feasibility, effectiveness, relevance, and impact. Peer-reviewed articles and public health data was utilized for this analysis. After a comparison of two policy options, the more favorable option was a revision to California’s minor consent laws to allow providers to confidentially treat addicted youth, 16 and older, with buprenorphine. This analysis showed how this policy will likely be more effective in narrowing the treatment gap among older adolescents. Recommendations, implications and potential limitations were also discussed."]},{"key":"dc:title","label":"Title","values":["Improving Minors' Access to Treatment for Opioid Use Disorder: A Policy Analysis"]}]}],"canonical_facts":{"dc:contributor":["Alexa Curtis"],"dc:creator":["Hamilton, Sara Jane"],"dc:date.available":["2024-01-29T08:00:00Z"],"dc:date.created":["2023-08-11T07:00:00Z"],"dc:description.abstract":["As the opioid epidemic continues to have devastating effects on our communities, medications to treat opioid use disorder (MOUDs) are severely underutilized especially for adolescents. Unlike adults, minors need parental approval before obtaining MOUDs presenting a key barrier to timely treatment. Being able to treat adolescents as soon as they are ready is critically important for people with OUD, and while cost and other barriers have been addressed in the literature, there is a paucity on how parental consent affects the accessibility of treatment. This paper aims to explore a potential policy in California that addresses the lack of access for adolescents. A health policy analysis format was used to compare and assess each policy option through a criteria of feasibility, effectiveness, relevance, and impact. Peer-reviewed articles and public health data was utilized for this analysis. After a comparison of two policy options, the more favorable option was a revision to California’s minor consent laws to allow providers to confidentially treat addicted youth, 16 and older, with buprenorphine. This analysis showed how this policy will likely be more effective in narrowing the treatment gap among older adolescents. Recommendations, implications and potential limitations were also discussed."],"dc:identifier":["https://repository.usfca.edu/capstone/1665"],"dc:subject":["Opioid use disorder","Minor consent","parental consent","policy analysis","California","Epidemiology","Health Services Administration","Other Mental and Social Health","Psychiatric and Mental Health","Substance Abuse and Addiction"],"dc:title":["Improving Minors' Access to Treatment for Opioid Use Disorder: A Policy Analysis"],"thesis:degree_discipline":["Public Health"],"thesis:degree_level":["Project/Capstone - Global access"],"thesis:degree_name":["Master of Public Health (MPH)"]},"updated_at":"2026-11-19T08:38:22Z"}